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OBJECTIVE — Theassociationbetweenchangesintriglycerideconcentrationsovertimeand
diabetes is unknown. We assessed whether two triglyceride determinations obtained 5 years
apart can predict incident type 2 diabetes.
RESEARCH DESIGN AND METHODS — Triglyceride levels at baseline (time 1) and 5
years later (time 2), followed by subsequent follow-up of 5.5 years, were measured in 13,953
apparently healthy men (age 26–45 years) with triglycerides 300 mg/dl (3.39 mmol/l).
RESULTS — During 76,742 person-years, 322 cases of diabetes occurred. A multivariate
model adjusted for age, BMI, total cholesterol–to–HDL cholesterol ratio, family history of dia-
betes, fasting glucose, blood pressure, physical activity, and smoking status revealed a contin-
uous independent rise in incident diabetes with increasing time 1 triglyceride levels (Ptrend 
0.001).Meninthelowesttertileoftime1triglyceridelevelswhoprogressedtothehighesttertile
over follow-up (low-high) exhibited a hazard ratio (HR) of 12.62 (95% CI 3.52–31.34) com-
pared with those remaining in the lowest tertile at both time points (reference group: low-low).
Whereasmenwhowereatthetoptriglycerideleveltertilethroughoutfollow-up(high-high)had
a HR for diabetes of 7.08 (2.52–14.45), those whose triglyceride level decreased to the lowest
tertile (high-low) exhibited a HR of 1.97 (0.67–6.13). Alterations in triglyceride levels during
follow-upwereassociatedwithchangesinBMI,physicalactivity,andeatingbreakfasthabit(P
0.05), but remained an independent modiﬁer of diabetes risk even after adjustment for such
changes.
CONCLUSIONS — Two measurements of fasting triglyceride levels obtained 5 years apart
can assist in identifying apparently healthy young men at increased risk for diabetes, indepen-
dent of traditional risk factors and of associated changes in BMI and lifestyle parameters.
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E
levated triglyceride levels are a com-
mon dyslipidemic feature accompa-
nying type 2 diabetes and pre-
diabetic states (1). A fasting triglyceride
level of 150 mg/dl (1.70 mmol/l) is
one of ﬁve accepted criteria for deﬁning
individuals at high risk for cardiovascular
disease and type 2 diabetes, arguably
termed the “metabolic syndrome” (2–4).
Some evidence suggests that fasting tri-
glyceride levels can aid in predicting fu-
ture type 2 diabetes (5,6). However, this
was shown mainly when triglyceride levels
were combined with additional clinical pa-
rameters, such as BMI, blood pressure (7),
and other classic risk factors for cardiovas-
cular disease (8,9), or with “high-normal”
fasting plasma glucose levels (10).
Thelevelofcirculatingtriglyceridesis
highly inﬂuenced by the fed-fasted state,
insulin sensitivity, and lifestyle factors
such as diet and physical activity
(1,11,12). These make triglyceride levels
a highly sensitive lifestyle biomarker at a
giventimepointbutsuggestthatatriglyc-
eride determination at a single time point
may inaccurately reﬂect long-term triglyc-
eridemia, particularly if lifestyle modiﬁca-
tion occurred during follow-up. Whether
assessment of triglyceride levels at more
than one time point could improve the as-
sociationbetweentriglyceridelevelsanddi-
abetes is largely unknown. Recently, we
reported in a large cohort of young (aged
26–45 years) men that signiﬁcant changes
between two fasting triglyceride measure-
ments obtained 5 years apart corresponded
with alterations in lifestyle parameters (13).
Furthermore, such changes modiﬁed the
risk for heart disease attributed to elevated
triglyceride levels (13).
Most studies assessing the risk factors
for type 2 diabetes have overlooked the
parameters speciﬁcally relevant for the
apparently healthy young adult popula-
tion. Although the incidence rate of dia-
betesinthisgroupisrelativelylow,recent
studies suggested a surge in type 2 diabe-
tes in young adults (14). Identifying indi-
vidualsinthisgroupwhohaveahighrisk
of developing diabetes is therefore chal-
lenging but potentially of signiﬁcant ben-
eﬁt if preventive measures are used. Here,
we used the cohort of young, apparently
healthy men (10,13) to assess whether
baseline triglyceride measurements as
well as lifestyle-associated changes in tri-
glyceride levels over time can predict the
risk of diabetes.
RESEARCH DESIGN AND
METHODS
The MELANY cohort
TheMetabolic,Life-Style,andNutritional
Assessment in Young Adults (MELANY)
study is based on a computerized data-
base established in 1992 that includes all
medical records of Israel Defense Forces
(IDF)careerservicepersonnel,asdetailed
previously (10,13). Of this population,
95% are Caucasians. During every visit
to the staff periodic examination center,
participants complete a detailed ques-
tionnaire assessing demographic, nutri-
tional, lifestyle, and medical parameters.
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recorded by trained medics, venous
blood samples are obtained after a 14-h
fast,andacompletephysicalexamination
is performed by physicians. Between vis-
its, primary care for IDF personnel is ob-
tained at designated military clinics, and
all medical information is recorded in the
same central database.
The IDF Medical Corps Institu-
tional Review Board approved this
study, which was exempt from the re-
quirement for written informed consent
onthebasisofmaintainingparticipants’
anonymity. IDF authorities did not cen-
sor or limit any aspect of the study de-
sign, analyses, and reporting.
Criteria for inclusion, exclusion, and
outcome
Women were not included, as the data-
base contains an insufﬁcient number of
incident cases of diabetes to facilitate
meaningful analyses. Included are appar-
ently healthy men aged 26–45 years,
with fasting triglyceride levels 300
mg/dl(3.40mmol/l)attheirinitialvisit.
Of 15,165 men who had at least two vis-
its, the following were excluded because
they were referred for nutritional/
pharmacological intervention: 227 men
with diabetes and 17 men with coronary
heart disease at baseline and 686 men
with triglyceride levels of 300 mg/dl
(3.40 mmol/l). An additional 282 men
were excluded because they received
chronic medications.
Two analyses are presented. Analysis
1 determined the association between tri-
glyceride values at enrollment (time 1)
and incident diabetes during 10 years of
follow-up. Analysis 2 evaluated the effect
of change in fasting triglyceride level be-
tween two measurements: time 1 at en-
rollment and time 2 obtained 5 years
later. In this analysis, the time 2 value be-
came the baseline measurement (time 1
turning into a historical, prebaseline deter-
mination), and incident diabetes was as-
sessedinthesubsequent5.2yearsoffollow-
up. For analysis 1, 13,953 men were
included, and the predictive value of time 1
triglyceride measurement for incident dia-
betes was assessed. For analysis 2, an addi-
tional 413 men were excluded: 363 did not
havetriglycerideresultsattime2,andin38
and 12 men diabetes or coronary heart dis-
ease was diagnosed, respectively, between
time 1 and time 2. Therefore, analysis 2 in-
cluded 13,540 men.
Diagnosis of type 2 diabetes was de-
ﬁned as the primary study end point. All
cases of diabetes were diagnosed accord-
ing to the American Diabetes Association
Expert Committee criteria (15). The diag-
nosis of all 322 incident cases of diabetes
was based on two fasting plasma glucose
levels of 126 mg/dl (7.00 mmol/l).
End point determination was made at
each sequential staff periodic examina-
tion center visit by measuring fasting glu-
cose levels. Between visits, diabetes was
diagnosed by the IDF primary care physi-
cian (15), and the diagnosis was reviewed
by a military physicians’ committee.
Laboratory methods
Fresh blood samples were analyzed in a
core laboratory facility. The laboratory is
authorized according to international
quality standard ISO-9002 and is subject
toperiodicqualitycontrolassessment(by
the British National External Quality As-
sessment Service). For venous fasting
plasma glucose determinations, blood
samples were collected in sodium ﬂuo-
ride–containing tubes. All biochemical
parametermeasurementswereperformed
using a BM/Hitachi 917 automated ana-
lyzer (Boehringer Mannheim).
Statistical analysis
A general linear model was used to assess
the age-adjusted means and proportions
of the population’s characteristics across
quintiles of triglyceride levels and to ﬁt
the median of the quintiles as a continu-
ous variable to estimate the trend of vari-
ables across quintiles. For analysis 1, we
conducted a Cox proportional hazards
analysis during each interval of follow-up
to estimate the hazard ratios (HRs) and
95% CIs for the development of diabetes
according to triglyceride levels of time 1
(ﬁrst measurement). In stepwise models,
values for BMI, fasting plasma glucose,
and family history of diabetes were added
separately into the age-adjusted model to
evaluate the potential role of each as a
confounder. In the ﬁnal multivariate
model, we controlled for age, BMI, total
cholesterol–to–HDL cholesterol ratio,
family history of diabetes, fasting plasma
glucose, mean arterial blood pressure,
physical activity, and smoking status.
For analysis 2, triglyceride levels at
both time 1 and time 2 were cross-
classiﬁed by tertiles. In parallel, we deter-
mined changes in BMI, smoking status,
physical activity, and pattern of eating
breakfast between time 2 and time 1.
Next, we evaluated the joint risk attrib-
uted to triglyceride levels at time 1 and
time 2; categorized them according to
low, intermediate, and high tertiles; and
used the group of men in the low-low tri-
glyceride level group as a reference group
(HR  1). To evaluate the direct associa-
tion of triglyceride level changes, we fur-
ther adjusted for the changes between
time 2 and time 1 in BMI, physical activ-
ity, smoking, and eating breakfast pattern
in a ﬁnal multivariate model. In this anal-
ysis, we added the calculated differences
(s) of BMI, and for categorical variables
we created four groups, describing the
positiveornegativestatesattime1/time2
of smoking, physical activity, and eating
breakfast pattern (yes/yes, yes/no, no/yes,
and no/no). All statistical analyses were
performed using SAS statistical software
(version 9.1; SAS Institute, Cary, NC).
RESULTS— We analyzed data from
13,953 apparently healthy men (mean
age 32.4 years; range 26–45 years) with
triglyceride levels 300 mg/dl (3.40
mmol/l) at enrollment (time 1). Age-
adjusted values for BMI, LDL cholesterol,
and fasting plasma glucose levels, as well
as the proportion of men with a family
history of diabetes and the percent that
werecurrentsmokers,weremorelikelyto
increase across triglyceride quintiles (Ta-
ble1).Concomitantly,levelsofHDLcho-
lesterol and the proportion of men who
were physically active or who reported
eating breakfast regularly were more
likely to decrease across quintiles of tri-
glyceride levels.
Analysis 1
During nearly 77,000 person-years
(mean follow-up 10.5 years), there were
322 documented incident cases of type 2
diabetes. Age-adjusted HRs for diabetes
increased across quintiles of triglycerides
(Table 2), reaching 4.77 (95% CI 3.22–
7.06) for the top quintile compared with
thebottomquintile(Ptrend0.001).Fur-
ther adjustment for BMI attenuated the
risk values to 2.61 for the top quintile
(1.75–3.91). The upper two quintiles of
triglyceride (median triglyceride 138
mg/dl[1.57mmol/l]and204mg/dl[2.31
mmol/l]) remained signiﬁcantly associ-
ated with elevated diabetes risk when
plasma glucose and family history of dia-
betes,twoindependentriskfactorsfordi-
abetes in this population (10), were
added to the model. Furthermore, a mul-
tivariate model adjusting for age, BMI, to-
tal cholesterol–to–HDL cholesterol ratio,
family history of diabetes, glucose levels,
mean arterial blood pressure, physical ac-
tivity, and smoking status revealed a sig-
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tributable to triglyceride levels in quin-
tiles 4 and 5 (HR 1.72 [95% CI 1.12–
2.64)] and 2.11 [38–3.22], respectively),
compared with the bottom quintile (me-
dian triglyceride level 53 mg/dl [0.60
mmol/l]). To exclude the possibility that
elevated triglyceride levels already re-
ﬂected a clinically unrecognized diabetic
state at baseline, the ﬁndings above were
conﬁrmedinasecondaryanalysisthatex-
cluded individuals whose diagnosis of di-
abeteswasmadewithintheﬁrst2yearsof
follow-up (data not shown).
Analysis 2
We next evaluated the association be-
tween changes in triglyceride levels and
Table 1—Baseline characteristics of 13,953 young adult men across quintiles of triglycerides (time 1)
Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 Ptrend
Total
(mean)
n 2,844 2,739 2,789 2,795 2,786 13,953
Triglyceride level (mg/dl)
Mean 52  9.6 78.1  6.9 104  8.4 139  12.6 212  35.7 116.9
Median (25th, 75th) 53 (45, 60) 78 (72, 84) 104 (97, 111) 138 (128, 150) 204 (182, 236)
Range 30–66 67–90 91–119 120–163 164–299
Age (years) 31.0  4.8 31.7  5.1 32.3  5.3 33.0  5.4 33.9  5.2 0.001 32.4
Mean follow-up (years) 10.4 10.3 10.1 10.6 10.7 0.58 10.4
Age adjusted
Family history of type 2
diabetes (%)* 16.0 16.7 16.7 21.0 23.2 0.001 18.7
BMI (kg/m2) 24.0  3.1 24.7  3.4 25.5  3.5 26.3  3.5 27.3  3.6 0.001 25.6
Blood pressure (mmHg)
Systolic 117  11.4 119  11.6 120  12.2 121  12.3 122  12.6 0.001 119.8
Diastolic 75.0  8.4 76.3  8.6 77.1  9.1 77.8  9 78.9  9.7 0.001 77.0
Mean arterial pressure 88.4  8.6 89.2  8.7 90.5  9.4 91.2  9.3 92.3  9.8 0.001 90.3
Smoking status (%)
Current 22.0 27.7 29.7 32.9 37.0 0.001 29.8
Former 20.0 18.5 22.0 19.8 20.5 0.81 20.2
Physical activity
60 min/week (%) 13.0 11.8 9.0 9.3 6.6 0.001 9.9
Minutes per week (mean) 91 89 88 81 83 0.057 86.4
Eating breakfast (%)† 22 19.3 17.7 17.9 16.4 0.002 18.7
Biomarkers
HDL cholesterol (mg/dl) 54.0  11.2 48.2  10.5 47.1  9.8 44.3  9.8 40.8  9.6 0.001 46.9
Total cholesterol–to–HDL
cholesterol ratio 3.70  0.9 4.28  1.1 4.80  1.3 5.34  1.5 6.03  1.6 0.001 4.8
Fasting plasma glucose (mg/dl) 89.0  9.7 90.3  9.6 91.4  9.8 92.0  10.1 93.3  10.3 0.005 91.2
Data are means  SD unless indicated otherwise. Values represent the ﬁrst of two repeated measurements of triglycerides within a 5-year interval. *A family history
for type 2 diabetes indicates the presence of type 2 diabetes in a ﬁrst-degree relative. †Eating breakfast denotes the percentage of persons reporting eating breakfast
regularly. To convert the values for triglycerides to millimoles per liter, multiply by 0.0113. To convert the values for glucose to millimoles per liter, multiply by
0.0555. To convert the values for cholesterol to millimoles per liter, multiply by 0.0259.
Table 2—HRs for type 2 diabetes among 13,953 young adult men across quintiles of triglyceride levels
Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 Ptrend
Triglyceride (mg/dl) 30–66 67–90 91–119 120–163 164–299
Person-years of follow-up 15,941 15,115 15,340 15,428 15,100
No. incident cases of type 2 diabetes 22 41 43 79 137 0.001
Adjusted risk ratio (95% CI)
Age 1 1.49 (0.94–2.35) 1.72 (1.10–2.68) 2.88 (1.90–4.36) 4.77 (3.22–7.06) 0.001
Age and BMI 1 1.21 (0.77–1.93) 1.34 (0.86–2.08) 1.89 (1.24–2.87) 2.61 (1.75–3.91) 0.001
Age, BMI, and FPG 1 1.16 (0.73–1.83) 1.23 (0.79–1.92) 1.69 (1.11–2.57) 2.13 (1.42–3.19) 0.001
Age, BMI, FPG and family history of
diabetes* 1 1.18 (0.75–1.87) 1.25 (0.80–1.95) 1.72 (1.13–2.61) 2.10 (1.40–3.14) 0.001
Multivariate† 1 1.15 (0.73–1.82) 1.24 (0.78–1.94) 1.72 (1.12–2.64) 2.11 (1.38–3.22) 0.001
*Family history of diabetes is a reported ﬁrst-degree relative with type 2 diabetes †The multivariate Cox regression model was adjusted for age, BMI, total
cholesterol–to–HDLcholesterolratio,fastingplasmaglucose,meanarterialbloodpressure(continuousvariables),familyhistoryofcoronaryheartdisease(positive,
negative, or missing information), physical activity (yes, no, or missing information), and smoking status (current smoker, noncurrent smoker, or missing
information). To convert the values for triglycerides to millimoles per liter, multiply by 0.0113.
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13,540 men as described in RESEARCH DE-
SIGN AND METHODS. Triglyceride levels at
time 1 and time 2 were divided into ter-
tiles (low, intermediate, and high), and
diabetes risk was assessed using the mul-
tivariate model described above during
the mean 5.2 years after time 2. Consis-
tent with analysis 1 (Table 2), the risk of
incident diabetes was 2.01-fold higher
(95% CI 1.20–4.38) in the high tertile of
time 1 triglyceride levels compared with
that for the low tertile (Ptrend  0.001).
Adding time 2 triglyceride levels resulted
in nine groups cross-classiﬁed according
to triglyceride level at both time points,
for which the HR for diabetes was calcu-
lated and expressed using individuals in
thelowtertileoftriglyceridelevelsatboth
time points (low-low) as the reference
group (Fig. 1A). In this group the inci-
dence rate of diabetes during follow-up
was52.2casesper10,000individuals(16
casesof3,066).Inthemultivariatemodel,
which now also controlled for the time
interval between time 1 and time 2, the
HRs for diabetes were 3.17 (95% CI
1.09–8.67) and 7.08 (2.52–14.45) in in-
dividuals with triglyceride levels at both
time points in the intermediate- or high-
tertile levels, respectively. By contrast, in-
dividuals who had low time 1 triglyceride
but whose triglyceride levels increased to
intermediate or high tertiles in time 2
were 4.47 (95% CI 1.37–9.48) and 12.62
(3.52–31.34) times, respectively, more
likely to develop diabetes compared with
thoseremainingwithlowtriglyceridelev-
els at time 2 (low-low). Importantly, time
2 triglyceride values also modiﬁed diabe-
tes risk in those with triglyceride levels in
the high tertile at time 1: HR for diabetes
was 7.08 in the high-high compared with
the low-low group, but decreased to 4.28
(95% CI 1.42–9.69) and 1.97 (0.67–
6.13) in individuals whose time 2 triglyc-
eride levels decreased to intermediate or
low tertiles, respectively.
In a recent article (13), we character-
izedthelow-lowandhigh-high(aswellas
low-high and high-low) groups repre-
senting individuals with stable or dy-
namic triglyceride levels during follow-
up, respectively. Men in the low-low
Figure 1—Association between changes in triglyceride levels and future morbidity (analysis 2). A: Multivariate model showing the association
between fasting serum triglyceride levels obtained at two measurements 5 years apart* and incidence of type 2 diabetes. The multivariate Cox
regression model was adjusted for age, BMI, total cholesterol–to–HDL cholesterol ratio, fasting plasma glucose, time lapse between time 1 and time
2 determinations, and mean arterial blood pressure as continuous variables and physical activity (yes, no, or missing information), family history
of diabetes (positive, negative, or missing information), and smoking status (current, noncurrent smoker, or missing information). To convert the
valuesfortriglyceridestomillimolesperliter,multiplyby0.0113.B:MultivariatemodelcomparingHRsfordiabetesorheartdiseaseassociatedwith
fasting triglyceride levels in two measurements 5 years apart*. The model was adjusted, as in A, for age, family history of coronary heart disease
(positive, negative, or missing information), interval between time 1 and time 2, time 1 levels of fasting plasma HDL cholesterol, glucose, mean
arterial blood pressure, and BMI (as continuous variables). In addition, the model was adjusted for the changes between time 1 and time 2 in BMI,
physical activity (nonactive/nonactive, nonactive/active, active/nonactive, or active/active), smoking status (current/current, current/noncurrent,
noncurrent/current,ornoncurrent/noncurrent),andhabitofeatingbreakfast(no/no,no/yes,yes/no,oryes/yes).Theresultsregardingheartdisease
have been published in Ref. 13. *Time 1 is determination at enrollment; time 2 is determination obtained 5 years after time 1 determination. In this
analysis (analysis 2), follow-up begins from time 2, as detailed under RESEARCH DESIGN AND METHODS.
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toretainalowerBMI,maintainhighphys-
ical activity parameters, and continue a
high percentage of reported habit of eat-
ing breakfast. Importantly, men in the
high-low group, i.e., those whose triglyc-
eride decreased between time 1 and time
2 from the high to the low tertile without
lipid-lowering medication, were the only
group of the four whose BMI decreased.
Furthermore, they were the group who
exhibited the highest increase in physical
activity and percentage of individuals re-
porting eating breakfast regularly.
To assess whether changes in triglyc-
eride had a risk-modifying effect beyond
changes in BMI, physical activity, smok-
ing, and eating breakfast habit, the HRs
for diabetes were further adjusted for the
changeintheseparameters.Inthismodel,
dynamic changes in triglyceride levels re-
mained a signiﬁcant modifying factor of
the risk of incident diabetes: individuals
whose triglyceride levels progressed from
the low to the high tertile had a HR for
diabetes of 7.32 (95% CI 2.62–20.70)
comparedwiththoseremainingatthelow
triglyceride tertile at both time points.
Conversely, in those whose triglyceride
levels decreased from the high to the low
tertile, the HR for diabetes was 1.56
(0.33–7.40), not signiﬁcantly different
from that for those who retained low tri-
glyceride levels at both time points. The
comparison with the association between
changesintriglyceridelevelandheartdis-
ease in a model controlling also for the
change in BMI and lifestyle factors in the
same population (13) is described in Fig.
1B. Stable high triglyceride levels (high-
high group) increased the risk of heart
disease eightfold and the risk of diabetes
fourfoldcomparedwiththestablelowtri-
glyceride level group. However, young
men with an initial high triglyceride level
followedbyalifestyle-associateddecrease
intriglycerideleveltothelowlevelattime
2 (high-low group) had a HR of 4.9 for
heart disease, representing a lower risk
thanthatobservedinthehigh-highgroup
but still signiﬁcantly elevated compared
with that for the low-low group. In con-
trast, risk of diabetes among the high-low
group was statistically indistinguishable
from that for men with stable low tertile
triglyceride levels.
CONCLUSIONS — Three major ob-
servations emerge from this study on tri-
glyceride level as an independent risk
predictor for future type 2 diabetes in
young men. First, baseline triglyceride
level was found in our large-scale cohort
of young men to be an independent risk
factor for diabetes during  10 years of
follow-up. Second, two triglyceride mea-
surements 5 years apart revealed that in
individuals whose triglyceride level
changed, diabetes risk was correspond-
ingly modiﬁed: diabetes risk increased
12-fold if the triglyceride level in-
creased between time 1 and time 2 from
the lowest to the highest tertile. Con-
versely, in individuals with triglyceride
levels at the high tertile in the ﬁrst deter-
mination, diabetes risk changed from a
HR of 7 to 2 if the second triglyceride
measurement was in the low tertile range
(compared with the low-low group). Im-
portantly, such triglyceride level changes
were not related to initiation of lipid-
lowering therapy but instead were associ-
ated with measurable changes in lifestyle
parameters (13). This seemingly tight as-
sociation between dynamic triglyceride
level and diabetes risk not only strength-
ens the role of triglyceride levels in deter-
miningdiabetesriskbutalsosigniﬁesthat
triglyceride level is a sensitive biomarker
for lifestyle habits related to the risk of
developing diabetes. Third, fasting tri-
glyceride level predicts incident diabetes
in a more “acute” manner than it associ-
ateswithheartdisease.Thisisreﬂectedby
the facts that 1) individuals with initial
lowbutsubsequenthightriglyceridehave
a higher HR even compared with those
with stable high levels at both time points
and 2) in the high-low group, which ex-
hibited positive lifestyle changes, a HR
statistically indistinguishable from that
for those with stable low triglyceride lev-
els was observed. Both phenomena are
not present in the association between
changes in triglyceride level and heart
disease in the same population (Fig.
1B). Thus, although type 2 diabetes and
heart disease share multiple common
risk factors, a shorter “metabolic mem-
ory” of triglyceride levels may underlie
the pathogenesis of diabetes versus
heart disease, at least in the young, ap-
parently healthy male population.
The strengths and weaknesses of this
cohort have been discussed in detail in
previous publications (10,13). Worth
mentioning here is the fact that baseline
measurements are highly similar to those
of other published cohorts of young
adults (16,17), possibly excluding the
“healthy worker bias” in our cohort. Sec-
ond, although we could not draw conclu-
sions regarding the relation between
triglyceride level and diabetes in women,
a previous study assessing a cohort of 39-
to 65-year-old Swedish women also re-
ported triglyceride level as an indepen-
dent diabetes risk factor (5). Third,
althoughlaboratoryparametersdonotin-
clude advanced measurements such as
circulatinginsulinlevels,theyconstitutea
set of routine tests that are typically avail-
able to the practicing physician but not
routinely screened in young adults. Fi-
nally, the large size of the cohort enabled
us to deﬁne subgroups with a relatively
high risk for development of type 2 dia-
betesinapopulationotherwisecharacter-
ized by a low background incidence rate
of the disease.
Baseline triglyceride levels were
foundtobeanindependentriskfactorfor
diabetesinourcohortofyoungmen,even
after adjustment for metabolic parame-
ters, clinical variables, and lifestyle in-
dexes.Manyofthesefactorsareknownto
be tightly correlated with triglyceride
(11,12). Consistently, controlling for
these parameters in the stepwise multi-
variate model demonstrated a marked at-
tenuation of the diabetes risk associated
with higher quintiles of triglyceride level.
Nevertheless, a signiﬁcantly elevated HR
was observed in the multivariate model
for individuals with triglyceride levels at
the fourth and ﬁfth quintiles (i.e., already
at triglyceride levels 120 mg/dl [1.36
mmol/l]) compared with those at the bot-
tom quintile (triglyceride level of 66
mg/dl [0.75 mmol/l]). The notion that
triglyceride level constitutes an indepen-
dent diabetes risk factor was proposed by
several studies on cohorts of older indi-
viduals or of women (5,6,8,9). Here, we
also show the relevance of triglyceride
measurements for diabetes risk assess-
ment in the young adult, apparently
healthy, male population.
Themodifyingeffectofchangesintri-
glyceride levels on diabetes risk provides
potential new insights into diabetes pre-
vention strategies and mode of action of
lifestyle modiﬁcation. Compared with
pharmacological intervention with met-
formin, lifestyle modiﬁcation showed su-
perior efﬁcacy in preventing diabetes
(18). The close association observed be-
tween changes in triglyceride levels and
alterations in BMI, physical activity, and
eating habits (13) suggests triglyceride
level as a sensitive lifestyle biomarker that
is relevant to diabetes risk assessment. In-
triguingly, dynamics in triglyceride levels
remained a signiﬁcant determinant of di-
abetes risk even after adjustment for the
accompanying changes in BMI, smoking,
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(Fig. 1B). This may suggest an effect of
triglyceride on diabetes risk that is inde-
pendentoflifestylefactorsaltogetherand,
indeed,conditionssuchasfamilialhyper-
triglyceridemia suggest that genetic fac-
tors can determine triglyceride levels.
Alternatively, lifestyle factors that were
unaccounted for in this study may medi-
ate the change in triglyceride and/or the
associated modiﬁcation of diabetes risk.
Circulating triglyceride levels repre-
sent a balance between triglyceride syn-
thesis and utilization (1). These are
greatly affected by lifestyle factors (nutri-
tional habits and exercise) and by insulin
sensitivity.Consistently,anincreasingtri-
glyceride level, particularly when accom-
panied by low HDL, was shown to be a
surrogate marker of insulin resistance
(19), a strong predisposing condition for
type 2 diabetes. Furthermore, high free
fatty acids potentially derived from tri-
glyceride may further deteriorate insulin
sensitivity (20), creating a vicious cycle
between triglyceride level and insulin re-
sistance. Such a process may have oper-
ated to acutely increase diabetes risk
when triglyceride levels progressed dur-
ingfollow-upfromthelowesttothehigh-
est tertile, potentially surpassing the
excessive risk associated with persistently
elevated triglyceride levels. Finally, im-
proving insulin sensitivity and glucose
tolerance by pharmacological means de-
creased circulating free fatty acids or tri-
glyceride levels (21–23). Thus, although
our observational study falls short in un-
raveling cause-effect relationships, it is
tempting to speculate that lowering tri-
glyceride levels, either pharmacologically
or through lifestyle modiﬁcation, may
constitute a viable means to attenuate di-
abetes risk in apparently healthy young
men.
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